(SeaPRwire) - 此前，英国朋克说唱二人组 Bob Vylan 在格拉斯顿伯里音乐节上高呼“以色列国防军去死”
英国广播公司 (BBC) 宣布，将不再播出或直播被认为“高风险”的表演。此前，这家英国公共广播公司因播出朋克说唱二人组 Bob Vylan 在格拉斯顿伯里音乐节上的表演而面临强烈反对，该组合在演出期间高呼反对以色列军方。
该组合的主唱鼓励观众高呼“Death, death to the IDF（以色列国防军去死）” 和 “From the river to the sea, Palestine must be, will be, inshallah, it will be free（从河流到海洋，巴勒斯坦必须，将会，愿主保佑，将会自由）”。社交媒体上流传的视频显示，人群呼应着这些口号，有些人挥舞着巴勒斯坦国旗。
“我们对这种冒犯性和应受谴责的行为出现在 BBC 上深感遗憾，并想向我们的观众、听众，特别是犹太社区道歉，” 该广播公司在周四发布的一份声明中表示。
BBC 指出，该乐队在音乐节前被列为“高风险”乐队，与其他六个乐队一起，但在“适当的缓解措施”下仍被允许演出。该公司承认在合规流程中存在“错误”，并确认 Bob Vylan 的演出已从 BBC iPlayer 和 BBC Sounds 中永久删除。
该媒体承诺今后将在大型音乐节和活动中提供现场编辑政策支持。它还宣布计划发布更清晰的关于撤回直播的标准指南。
Avon and Somerset Police 已经对潜在的公共秩序犯罪展开刑事调查，称他们“将密切考虑所有适用的法律，包括与仇恨犯罪相关的法律。” 英国首相基尔·斯塔默谴责 BBC 播出该表演；媒体监管机构 Ofcom 表示，该广播公司有待回答的问题。
以色列驻伦敦大使馆表示，它“对舞台上表达的煽动性和仇恨言论深感不安”，称其为“种族清洗的倡导。”
本周早些时候，美国当局以国家安全为由，在这次有争议的表演之后，吊销了 Bob Vylan 成员的签证。该二人组原定于今年晚些时候开始为期 20 天的美国巡演，此后已被他们的经纪公司 United Talent 解约。
自以色列在加沙采取军事行动以来，许多国家都报告了支持巴勒斯坦的示威活动和反犹太事件的增加，自 2023 年以来，已有超过 56,000 名巴勒斯坦人丧生。这场冲突是由 2023 年 10 月 7 日哈马斯的袭击引发的，袭击造成约 1,200 名以色列人死亡，超过 200 人被劫为人质。
本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。
分类: 头条新闻,日常新闻
SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
```
July 04, 2025 - (SeaPRwire) - Duo Li Duo Foods Corporation's "Hua Kui Gift Box" Triple-Roasted Seasoned Bamboo Salt was awarded the Silver Award at the 2025 Fun Food Taiwan Awards, praised by the judges as "a benchmark in cultural flavour interpretation with strong potential to promote gastronomic aesthetics." By fusing Eastern wellness wisdom with innovative packaging, it elevates salt into a medium of style and emotion.
Renowned for its classic Taiwanese flavours and repeatedly lauded on the international stage, Duo Li Duo Foods Corporation, together with its affiliate Hai Yi Foods Corporation, has once again excelled at the 2025 Fun Food Taiwan awards. Hailing from Tainan, this all-natural health food group secured two honours in the "New Taste Wave" competition: the Whole Boneless Milkfish Tail and the Oiran Gift Box featuring Triple-Roasted Seasoned Bamboo Salt. Notably, the Triple-Roasted Seasoned Bamboo Salt won the Silver Award, a testament to the brand's unwavering commitment to "freshness, naturalness, health and flavour".
Since its inception in 2020, the New Taste Wave FUN FOOD TAIWAN selection has championed three core themes—clean, high-value products; experiential design; and sustainable convenience. For 2025, the competition advanced to its 2.0 phase, emphasising "product evolution, carbon-reduction realisation and enriched experiences". Of the 119 companies and 264 entries that vied for recognition, just 90 products emerged victorious. Duo Li Duo's two entries, blending cultural significance with technological innovation, exemplify how Taiwanese smallholder spirit and sustainable practices can elevate culinary standards.
Standing out among the finalists, the Oiran Gift Box's Triple-Roasted Seasoned Bamboo Salt series not only claimed Silver but was also praised by judges as "a benchmark for cultural flavour interpretation and gastronomic artistry". Beyond prioritising food safety and wellness, the product's design extends into ritualistic dining, eco-friendly packaging and multi-sensory experiences. By fusing Eastern medicinal wisdom with pioneering packaging, Duo Li Duo has proven that even table salt can convey style and evoke emotion.
General Manager of Raw Materials Wu Li-Ling explains that the "creative union" of traditional triple-roasted bamboo salt and locally sourced dried fruits transforms seasoning into an olfactory ceremony. Harvested from Taiwan's native bamboo groves and repeatedly fired at high temperatures to enhance its mineral richness, the salt is paired with slow-dried mango and pineapple to preserve their fruit aromas—offering a dual feast of taste and culture. "We named the gift box 'Oiran' to symbolise feminine grace, fragrant memory and refined ritual," she adds. "The exterior features Taiwanese floral motifs alongside contemporary illustrations, creating a next-generation sensory gift that balances health and heartfelt warmth."
Meanwhile, Hai Yi's signature offering—the Whole Boneless Milkfish Tail—also received acclaim. By removing every pin bone while preserving the fish's original form, and employing a symbiotic aquaculture model off the Tainan coast—where brackish ponds and grazing sheep coexist—the company has fashioned a micro-ecosystem benefiting fish, grass and livestock alike. Designed for versatility, the product can be steamed, pan-fried or air-fried, each method highlighting the milkfish's succulent texture and rich flavour, aligning perfectly with modern expectations of health, safety and environmental stewardship.
From humble beginnings in night markets, Duo Li Duo Foods Corporation has adhered to the credo "delivering the purest delight", minimising processing and shunning artificial colours and preservatives. Its portfolio—ranging from dried fruits and bamboo salt to premium seafood—has successfully penetrated markets in Japan, Hong Kong and Southeast Asia. Looking ahead, both Duo Li Duo and Hai Yi will pursue further accolades at international competitions such as Belgium's iTQi Superior Taste Award, the UK's Great Taste Awards and Monde Selection Gold, while showcasing at leading trade fairs including Paris SIAL, Germany's ANUGA, Tokyo's Foodex Japan and the US's Natural Products Expo.
Founder Wang Duo Li reflects, "Standing out from nearly three hundred outstanding entries across Taiwan reaffirms our team's dedication to local farmers, uncompromising quality and sustainable growth. We believe the simplest ingredients are often the rarest; by honouring original flavours and meticulous craftsmanship, we can rekindle consumers' connection to the land. Duo Li Duo is more than a food producer—we are building an innovative culinary movement rooted in Taiwan yet spoken in a global tongue."
Looking to the future, Duo Li Duo and Hai Yi have launched a series of international expansion initiatives. In partnership with like-minded global collaborators, they will focus on developing new bamboo-salt-and-dried-fruit flavours, low-sodium seasonings with seasonal ingredients, and the digitisation of flavour-based cultural assets. Their ambition is for every Duo Li Duo product to serve as a delicious bridge between Taiwanese terroir, cultural heritage and consumers around the world.
EQS Newswire / 02/07/2025 / 09:56 UTC+8
On June 27, 2025, Uni-Bio Science Group Limited (the “Group”)grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the "drug, medical device and Aesthetics" field.
High-end medical aesthetics: GeneQueens series
At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy
skin condition.
GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin.
In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an "instant enjoyment" precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot.
2、金因敷 showcased a variety of new products
Meanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics.
金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care.
3、The latest research data was presented at CSD2025
It is worth mentioning that 肌顏態® also showcased the research data of "The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure" jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products.
As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice.
4、Academic speeches by several experts
Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®’ s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing.
In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time.
6、The signing ceremony reflects the market potential
Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: " We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the "Drugs, Medical device and Aesthetics" strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. "
Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as "皮優理".
The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value.
The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the "Drugs, Medical device and Aesthetics" strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.
About Uni-Bio Science Group
Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and sales of pharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has three GMP manufacturing bases in Beijing, Dongguan and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology. Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690.
End
02/07/2025 Dissemination of a Financial Press Release, transmitted by EQS News.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
